Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Give it a few weeks and discuss any changes (or lack thereof) with your healthcare provider at follow-up
Oct 2010;18(4):195-206
Retatrutide, development code LY3437943, is Eli Lilly's investigational triple hormone receptor agonist
The mechanism relies on these lipotropic agents enhancing liver function and fatty acid oxidation, though clinical evidence on efficacy remains limited and heterogeneous
As summarized earlier, ferroptosis arises from a dysregulated balance between pro-ferroptotic cues (e.g., labile iron accumulation and PUFA enrichment) and protective mechanisms, including the SLC7A11GSHGPX4 axis, GCH1BH4 pathway, FSP1CoQH2 system, DHODHCoQH2 cascade, and MBOAT1/2-mediated monounsaturated fatty acid (MUFA) synthesis (280282)
US$ 23.29
US$ 23.83
US$ 27.87
US$ 21.77
US$ 25.40
US$ 20.25
